Výsledky vyhledávání - "Qiang E. Zhang"

Supplementary Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer

Autor: Quynh-Thu Le, Qiang E. Zhang, John A. Ridge, George Shenouda, Stuart J. Wong, Wade L. Thorstad, Sue S. Yom, Christopher U. Jones, James A. Bonner, Andy M. Trotti, Peter B. Schiff, Steven J. Frank, Lucas K. Vitzthum, Kaveh Zakeri, David I. Rosenthal, Phuc Felix Nguyen-Tân, Hanjie Shen, Loren K. Mell

Supplementary Data: Tables S1-S2; Figures S1-S4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1689d62e59736f109603e8259032ebc3
https://doi.org/10.1158/1078-0432.22471442

Zobrazit plný text záznamu

Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer

Purpose:Previous studies indicate that the benefit of therapy depends on patients' risk for cancer recurrence relative to noncancer mortality (ω ratio). We sought to test the hypothesis that patients with head and neck cancer (HNC) with a higher ω

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f904e632f4fad6465278ca6933c2f2d
https://doi.org/10.1158/1078-0432.c.6527897.v1

Zobrazit plný text záznamu

Clinical outcomes in children and adolescents referred for increased cup-disc ratio at a tertiary referral center over 9 years

Autor: Mandy O. Wong, Qiang E. Zhang, Shaza N Al-Holou, Alex V. Levin

Publikováno v: Journal of American Association for Pediatric Ophthalmology and Strabismus. 25:e12-e13

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2146b7f7cd1042c878d2057171493fcc
https://doi.org/10.1016/j.jaapos.2021.08.049

Zobrazit plný text záznamu

Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer

Autor: Peter B. Schiff, Kaveh Zakeri, John A. Ridge, Stuart J. Wong, Sue S. Yom, James A. Bonner, Qiang E. Zhang, Andy Trotti, Hanjie Shen, Phuc Felix Nguyen-Tân, George Shenouda, Lucas K. Vitzthum, Quynh-Thu Le, Loren K. Mell, David I. Rosenthal, Wade L. Thorstad, Steven J. Frank, Christopher U. Jones

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 23
Clin Cancer Res

Purpose: Previous studies indicate that the benefit of therapy depends on patients' risk for cancer recurrence relative to noncancer mortality (ω ratio). We sought to test the hypothesis that patients with head and neck cancer (HNC) with a higher ω

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327f7b1b5219e64de9a3588932cc8c95
https://escholarship.org/uc/item/9b4469zc

Zobrazit plný text záznamu

Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials

Autor: James D. Murphy, Ruben Carmona, Lucas K. Vitzthum, Neil Panjwani, Loren K. Mell, Kaveh Zakeri, Hanjie Shen, Qiang E. Zhang

Publikováno v: JCO clinical cancer informatics, vol 2, iss 2
Zakeri, Kaveh; Panjwani, Neil; Carmona, Ruben; Shen, Hanjie; Vitzthum, Lucas K; Zhang, Qiang E; et al.(2018). Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials.. JCO clinical cancer informatics, 2(2), 1-12. doi: 10.1200/cci.17.00124. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1t22s7mk

Purpose Generalized competing event (GCE) models improve stratification of patients according to their risk of cancer events relative to competing causes of mortality. The potential impact of such methods on clinical trial power and cost, however, is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87189453ca0a51c99233188b84e783a5
https://escholarship.org/uc/item/1t22s7mk

Zobrazit plný text záznamu

Integrated phase II/III clinical trials in oncology : A case study

Autor: James J. Dignam, Minesh P. Mehta, Qiang E Zhang, John DeGroot, Sally Hunsberger, Meihua Wang

Background Integrated phase II/III trial designs implement the phase II and phase III aspects of oncology studies into a single trial. Despite a body of literature discussing the merits of integrated phase II/III clinical trial designs within the pas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fce14d6fe36d32d8fcfe5b6c1b546a25
https://europepmc.org/articles/PMC7099526/

Zobrazit plný text záznamu

Akademický článek

Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials.

Autor: Zakeri K; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Panjwani N; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Carmona R; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Shen H; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Vitzthum LK; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Zhang QE; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Murphy JD; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA., Mell LK; Kaveh Zakeri, Neil Panjwani, Hanjie Shen, Lucas K. Vitzthum, James D. Murphy, and Loren K. Mell, University of California San Diego, La Jolla, CA; Ruben Carmona, University of Pennsylvania; and Qiang E. Zhang, NRG Oncology Statistics and Data Management Center, Philadelphia, PA.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2018 Dec; Vol. 2, pp. 1-12.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání